BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28638157)

  • 21. [Cardiac surgery in Jehovah's Witnesses. Experience in Santander, Spain].
    Bernal JM; Naranjo S; Trugeda M; Sarralde A; Diago C; Revuelta JM
    Rev Esp Cardiol; 2006 May; 59(5):507-9. PubMed ID: 16750149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses.
    Stamou SC; White T; Barnett S; Boyce SW; Corso PJ; Lefrak EA
    Am J Cardiol; 2006 Nov; 98(9):1223-5. PubMed ID: 17056333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique.
    Rosengart TK; Helm RE; DeBois WJ; Garcia N; Krieger KH; Isom OW
    J Am Coll Surg; 1997 Jun; 184(6):618-29. PubMed ID: 9179119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repair of hypoplastic left heart syndrome of a 4.25-kg Jehovah's witness.
    Forest RJ; Groom RC; Quinn R; Donnelly J; Clark C
    Perfusion; 2002 May; 17(3):221-5. PubMed ID: 12017392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of outcome in Jehovah's Witness patients in cardiac surgery: an Australian experience.
    Bhaskar B; Jack RK; Mullany D; Fraser J
    Heart Lung Circ; 2010 Nov; 19(11):655-9. PubMed ID: 20813584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiopulmonary bypass in Jehovah's Witnesses.
    Frimpong-Boateng K; Aniteye E; Sereboe LA; Amuzu VO
    West Afr J Med; 2003; 22(1):92-4. PubMed ID: 12769317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use.
    Sobieski MA; Slaughter MS; Hart DE; Pappas PS; Tatooles AJ
    Perfusion; 2005 Jan; 20(1):31-7. PubMed ID: 15751668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery.
    Emmert MY; Salzberg SP; Theusinger OM; Felix C; Plass A; Hoerstrup SP; Falk V; Gruenenfelder J
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):183-8. PubMed ID: 20829389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac surgery in Jehovah's Witness patients: ten-year experience.
    Jassar AS; Ford PA; Haber HL; Isidro A; Swain JD; Bavaria JE; Bridges CR
    Ann Thorac Surg; 2012 Jan; 93(1):19-25. PubMed ID: 21978873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiopulmonary bypass management and acute kidney injury in 118 Jehovah's Witness patients: a retrospective propensity-matched multicentre cohort from 30,942 patients.
    Willcox TW; Newland RF; Baker RA
    Perfusion; 2020 Nov; 35(8):833-841. PubMed ID: 32106764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses).
    Gohel MS; Bulbulia RA; Slim FJ; Poskitt KR; Whyman MR
    Ann R Coll Surg Engl; 2005 Jan; 87(1):3-14. PubMed ID: 15720900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing Safety and Success: The Advantages of Bloodless Cardiac Surgery. A Systematic Review and Meta-Analysis of Outcomes in Jehovah's Witnesses.
    Gemelli M; Italiano EG; Geatti V; Addonizio M; Cao I; Dimagli A; Dokollari A; Tarzia V; Gallo M; Ferrari E; Slaughter MS; Gerosa G
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102078. PubMed ID: 37716536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of ultrafiltration on blood use for atrial septal defect closure in infants and children.
    Gurbuz AT; Novick WM; Pierce CA; Watson DC
    Ann Thorac Surg; 1998 Apr; 65(4):1105-8; discussion 1108-9. PubMed ID: 9564936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses.
    Vaislic C; Bical O; Farge C; Gaillard D; Ponzio O; Ollivier Y; Abdelmoumen Y; Robine B; Souffrant G; Bouharaoua T
    Heart Surg Forum; 2003; 6(5):307-10. PubMed ID: 14721799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of open heart surgery in Jehovah's Witnesses patients.
    Juraszek A; Dziodzio T; Roedler S; Kral A; Hutschala D; Wolner E; Grimm M; Czerny M
    J Cardiovasc Surg (Torino); 2009 Apr; 50(2):247-50. PubMed ID: 19329922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific requirements for bloodless cardiopulmonary bypass in neonates and infants; a review.
    Golab HD; Takkenberg JJ; Bogers AJ
    Perfusion; 2010 Jul; 25(4):237-43. PubMed ID: 20576727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jehovah's Witnesses--how to encounter the transfusion issue.
    Schmid C; Krempel S; Scheld HH
    Thorac Cardiovasc Surg; 2002 Dec; 50(6):380-3. PubMed ID: 12457321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bloodless third complex heart operation in a Jehovah's Witness patient with extremely low preoperative haemoglobin level.
    Pasic M; D'Ancona G; Unbehaun A; Hetzer R
    Interact Cardiovasc Thorac Surg; 2012 May; 14(5):692-3. PubMed ID: 22354090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte filtration and miniature perfusion during arrested heart CABG on a Jehovah's Witness patient.
    Sutton SW; Duncan MA; Chase VA; Cheung EH; Hamman BL
    Perfusion; 2004 Nov; 19(6):375-9. PubMed ID: 15619972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.